HECHT BETH (See Remarks) sold 1.5% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $156.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/2/2026ACC: 0001867096-26-000084
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$156.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.67K
Price / share
$9.41
Trade value
$156.79K
% of position
1.5%
10/1/2026
1.13M→1.11M
Total
Net shares
−16.67K
Net value
-$156.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | S · Sale | −16.67K | $9.41 | $156.79K | 1.5% | 1.13M | 1.11M |
| Total | −16.67K | -$156.79K | ||||||
Derivative Transactions0
No derivative transactions reported